Search
for
Sort by
Research 241–270 of 517
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- The influence of interferon on healthy and diseased skin
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Alopecia management from a comparative perspective: pharmacological and pharmaceutical insights in humans, dogs, and cats
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- Rare Cutaneous Side Effects of Imiquimod: A Review on Its Mechanisms, Diagnosis, and Management
- Oxidative Stress and Skin Diseases: The Role of Lipid Peroxidation
- Aggressive treatment in paediatric or young patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with future development of type III polyglandular autoimmune syndrome
- Lichen Planopilaris-Like Changes Arising within an Epidermal Nevus: Does This Case Suggest Clues to the Etiology of Lichen Planopilaris?
- Tertiary Lymphoid Organs at the Center Stage of Skin's Humoral Immunity
- Chronic graft versus host disease and skin
- Mechanisms of autophagy and their implications in dermatological disorders
- Follicular unit extraction [FUE] – One procedure, many uses
- The Efficacy and Psychoneuroimmunology Mechanism of Camouflage Combined With Psychotherapy in Vitiligo Treatment
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- The correlation between corona virus disease 2019 and alopecia areata: a literature review
- Pathogenesis of Chemical Leukoderma and Chemical‐Induced Vitiligo
- Dual improvement of alopecia areata and immune thrombocytopenia with baricitinib: a case report
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
- Comorbid Conditions Associated with Alopecia Areata: A Systematic Review and Meta-analysis
- A Case of Frontal Fibrosing Alopecia in a Patient with Primary Biliary Cirrhosis and Polymyalgia Rheumatica
- Alopecia Areata: An Updated Review for 2023
- Alopecia Areata: Treatment of Today and Tomorrow
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Two cases of alopecia areata treated with ruxolitinib: a discussion of ideal dosing and laboratory monitoring
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024